Filing Details

Accession Number:
0001181431-14-033367
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-02 17:58:47
Reporting Period:
2014-09-30
Filing Date:
2014-10-02
Accepted Time:
2014-10-02 17:58:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Plc HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1240116 J Robert Vaere De C/O Horizon Pharma Plc
Adelaide Chambers, Peter Street
Dublin, Ireland L2 8
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-09-30 112,166 $0.00 206,456 No 4 A Direct
Ordinary Shares Disposition 2014-09-30 51,942 $12.28 154,514 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Fully vested restricted stock units issued on the Separation Date as defined in that certain Executive Employment and Transition Agreement dated June 17, 2014.
  2. Includes 23,467 shares of the Company's ordinary shares acquired pursuant to an employee stock purchase program.
  3. Reflects restricted stock units surrendered via a net settlement to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit.